Navigation Links
PharmaNova Fuels Business Growth with Lacerta Bio Partnership
Date:3/7/2011

VICTOR, N.Y., March 7, 2011 /PRNewswire/ -- PharmaNova, Inc. (PharmaNova) announces an agreement with Lacerta Bio, Inc. whereby Lacerta Bio's experienced team of business development professionals will supplement PharmaNova's team in the U.S. and U.K. to support its 2011 business growth and expansion initiatives. Emphasis will be on widening PharmaNova's partnering base for its innovative, nanoparticle technology, NovaSperse(SM), including existing NovaSperse(SM) new product opportunities and other projects that are available from PharmaNova for licensing and further development by third parties.

"We are delighted to be working with Lacerta Bio," said Rodney Brown, President of PharmaNova. "We have known both of the Lacerta Bio Managing Partners for several years, and are confident that working together, we can rapidly expand both our out-licensing and Fee-For-Service initiatives."

NovaSperse(SM), PharmaNova's proprietary, high drug load nanoparticle technology, utilizes minimal excipients and does not require complex equipment or processes. The NovaSperse(SM) process can be used to improve the solubility and enhance the delivery and pharmacokinetic properties of formulations in ophthalmics, dermatology, parenterals, and for other routes of administration.

"We have followed the progress made by PharmaNova over the past few years," said Dr. Anand R. Baichwal, Managing Partner of Lacerta Bio. "The NovaSperse(SM) technology is an excellent approach for rapidly developing new formulations with real therapeutic benefits, and we are excited to be a part of it."

About PharmaNova

PharmaNova is a privately held pharmaceutical company, which sub-licenses cutting-edge drug technology with its pioneering origins at the University of Rochester, and which develops and partners valuable new products to address underserved medical needs. Our products are created by re-positioning and enhancing the properties of known drugs using our proprietary NovaSperse(SM) nanoparticle drug delivery technology. A major additional component of our business is contractual formulation development work applying NovaSperse(SM) technology to support the repositioning and enhancement of client-owned products and compounds.

For more information, please visit http://www.pharmanovaco.com or contact Rodney A. Brown, President, PharmaNova, Inc. at +1-585-413-4721.

About Lacerta Bio

Lacerta Bio, Inc. is a business development and licensing consultancy for life sciences and other healthcare-related companies. Located in New York, Lacerta Bio assists life sciences companies and their investors identify, assess, and execute business development and licensing opportunities. The company also provides consulting on market opportunity assessments, competitive intelligence, pipeline analysis, interim business development management, and business plan and presentation development.

For more information, please visit http://www.lacertabio.com or contact Lacerta Bio, Inc. at +1 718 395 9371.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE PharmaNova, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative
2. Paper or Plastic? Technology Fuels Gift Card Popularity and Access as an Alternative to Cash Incentives and Gifts
3. Kronos Announces First Quarter Business Update and Financial Results
4. Growth Achieved in Spherixs Health Sciences Consulting Business
5. ImaRx Therapeutics Transitions Business Strategy
6. Argonauta Communications Certified as Women-Owned Business by the Womens Business Enterprise National Council (WBENC)
7. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
8. Small Business Innovation Research Program Awards Grant to Biomoda
9. American Dairy Provides Business Update
10. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
11. Pharmos Issues Business Update on Dextofisopam Trial and Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page ... ... companies, investors, policymakers, and stakeholders crucial insight into Switzerland ... , home to some of the world,s most important international health institutions ... Roche, and with a number one ranking globally in terms of ease ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... A highly innovative, personalized cell-based treatment for a high-risk form of the ... from Children,s Hospital of Philadelphia today reported new ... (ALL). The physician-scientists presented findings at the annual meeting of ... . Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... ... “Life Will Never Be The Same” is a fictional tale about growing up with ... is the creation of published author, Kim T. Briggs, a self-described “big kid” who ... religion and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama ...
(Date:12/5/2016)... ... ... has joined the Retina Group of New York (RGONY) specializing in uveitis and ... and has been providing tertiary medical and surgical retinal care on Long Island for over ... peers. Growing up in a family of doctors, Dr. Shah emulated the role of ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... excellent way to ensure moisture measurements are consistently correct. However, regular performance ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This innovative ...
(Date:12/5/2016)... OH (PRWEB) , ... December 05, 2016 , ... ... engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy of ... in various healthcare settings. , Over the last 60 years, studies have ...
(Date:12/4/2016)... ... December 03, 2016 , ... "Perfect Harmony comes with 20 ... FCPX editors to create professional looking video in a matter of minutes," said ... a beautifully designed 3D environment for placing in personal media. Twenty pre-made layouts ...
Breaking Medicine News(10 mins):